Steven Albelda, MD

Steven M. Albelda, MD, discusses what he expects the future of chimeric antigen receptor T-cell use in solid tumors to look like.

Steven M. Albelda, MD, discusses the limited successes of CAR T cells in solid tumors.

Steve M. Albelda, MD, discusses the successes and downfalls of chimeric antigen receptor T cells in solid tumor research.